查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587216

凝血和止血測試市場：按測試類型、技術和應用分類 - 2025-2030 年全球預測

Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年凝血和止血檢測市場價值為52.9億美元，預計到2024年將達到58.8億美元，複合年成長率為11.28%，預計到2030年將達到111.8億美元。

凝血和止血檢查的範圍和定義包括評估血液凝固和維持止血平衡能力的診斷程序和技術。該測試對於識別出血性疾病、指導抗凝血治療以及手術全期和重症患者的管理至關重要。此需求涵蓋血友病、深層靜脈栓塞症、肺動脈栓塞的診斷和心臟病管理監測等臨床應用。最終用戶主要是醫院、診斷實驗室和門診外科中心。影響該市場的主要成長要素包括心血管疾病盛行率的增加、老年人口的增加、就地檢驗技術的進步以及新興國家醫療基礎設施的加強。最新的潛在機會在於人工智慧和機器學習的整合，以提高診斷的準確性和效率、個人化醫療以及針對家庭醫療保健環境的可攜式測試設備的開發。然而，先進測試設備的高成本、嚴格的監管核准以及發展中地區的意識有限等挑戰構成了重大障礙。專注於持續創新、監管合規和策略夥伴關係關係有助於緩解這些限制。有前景的研究和創新領域包括尋找新的生物標記以獲得更準確的凝血曲線、透過創新提高成本效益以及擴大遠距遠端醫療能力。公司可以利用因 COVID-19 爆發而加速的遠距離診斷和遠端醫療平台的成長趨勢，從而深入了解市場動態。該市場競爭激烈，既有老牌企業，也新興企業，大量的研究和發展正在進行中。為了推動業務成長，公司應考慮投資策略收購和聯盟，加強產品系列，並將其地理覆蓋範圍擴展到開拓的市場。平衡技術創新與可負擔性和可近性對於持續的市場擴張仍然很重要。

主要市場統計
基準年[2023] 52.9億美元
預測年份 [2024] 58.8億美元
預測年份 [2030] 111.8億美元
複合年成長率（%） 11.28%

市場動態：快速發展的凝血和止血測試市場的關鍵市場洞察

供需的動態交互作用正在改變凝血和止血檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球心血管和血液疾病盛行率上升
    • 診斷實驗室更多採用自動止血設備
    • 政府針對血友病意識採取的舉措
  • 市場限制因素
    • 全自動凝血系統相關的高成本
  • 市場機會
    • 對照護現場(POC)血液凝固檢驗的需求不斷成長
    • 凝血和止血檢測技術的進展
  • 市場挑戰
    • 嚴格而漫長的監管過程

波特五力：駕馭凝血和止血檢測市場的策略工具

波特的五力架構是了解凝血和止血檢測市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對凝血和止血檢測市場的影響

外部宏觀環境因素對凝血和止血檢測市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解凝血和止血檢測市場的競爭狀況

凝血和止血測試市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣凝血止血檢測市場廠商績效評價

FPNV定位矩陣是評估凝血和止血檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪凝血和止血測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，凝血和止血測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心血管和血液疾病盛行率正在上升
      • 診斷實驗室更多地引入自動止血設備
      • 政府是否有一項旨在提高血友病意識的措施？
    • 抑制因素
      • 全自動凝血系統相關的高成本
    • 機會
      • 對照護現場(POC)血液凝固檢驗的需求增加
      • 凝血和止血檢測技術進展
    • 任務
      • 嚴格且耗時的監管流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按測試類型分類的凝血和止血測試市場

  • 活化部份凝血活酵素時間
  • D-二聚體測試
  • 纖維蛋白原測試
  • 血小板功能檢查

第7章 凝血和止血檢測市場：依技術分類

  • 電化學技術
  • 機械技術
  • 光學技術

第8章凝血和止血測試市場：按最終用途

  • 診斷中心
  • 醫院
  • 就地檢驗

第9章 北美、南美凝血止血檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太凝血與止血檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲凝血止血檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Danaher Corporation
  • Diagnostica Stago SAS
  • F. Hoffmann-La Roche Ltd.
  • George King Bio-Medical, Inc.
  • Grifols, SA
  • Helena Laboratories Corporation
  • Medtronic PLC
  • Micropoint Biotechnologies Co., Ltd
  • Sekisui Chemical Co., Ltd.
  • Siemens AG
  • Sysmex Corporation
  • Tcoag Ireland Limited
  • Thermo Fisher Scientific Inc.
  • Werfen, SA
Product Code: MRR-434CCDA04D1D

The Coagulation & Hemostasis Testing Market was valued at USD 5.29 billion in 2023, expected to reach USD 5.88 billion in 2024, and is projected to grow at a CAGR of 11.28%, to USD 11.18 billion by 2030.

The scope and definition of coagulation and hemostasis testing encompass diagnostic procedures and technologies used to evaluate the blood's ability to clot and maintain hemostatic balance. This testing is crucial in identifying bleeding disorders, guiding anticoagulant therapy, and managing perioperative and critical care patients. Its necessity spans across clinical applications such as diagnosing hemophilia, deep vein thrombosis, pulmonary embolism, and monitoring heart disease management. End-users primarily include hospitals, diagnostic laboratories, and outpatient surgical centers. Key growth factors influencing this market include the increasing prevalence of cardiovascular diseases, rising elderly population, advancements in technology with point-of-care testing, and enhanced healthcare infrastructure in emerging economies. The latest potential opportunities lie in the integration of artificial intelligence and machine learning to enhance diagnostic accuracy and efficiency, personalized medicine, and the development of portable testing devices that cater to home healthcare settings. However, challenges such as high cost of advanced testing equipment, stringent regulatory approvals, and limited awareness in developing regions pose significant hurdles. A focus on continuous innovation, regulatory compliance, and strategic partnerships can mitigate these limitations. Promising areas of research and innovation include the exploration of novel biomarkers for more precise coagulation profiles, improving cost-effectiveness through technological innovations, and expanding telemedicine capabilities. Businesses can gain insights into market dynamics by tapping into the growing trend of remote diagnostics and telehealth platforms, which were accelerated by the COVID-19 pandemic. The nature of the market is highly competitive with a mix of established players and startups driving substantial research and development. To foster business growth, companies should consider investing in strategic acquisitions or collaborations, enhancing product portfolios, and expanding geographical reach to underserved markets. Balancing technological innovation with affordability and accessibility remains crucial for sustained market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 5.29 billion
Estimated Year [2024] USD 5.88 billion
Forecast Year [2030] USD 11.18 billion
CAGR (%) 11.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coagulation & Hemostasis Testing Market

The Coagulation & Hemostasis Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the Prevalence of cardiovascular diseases and blood disorders globally
    • Increasing adoption of automated hemostasis equipment in diagnostic laboratories
    • Availability of government initiatives focusing on awareness of hemophilia
  • Market Restraints
    • High cost associated with fully automated coagulation systems
  • Market Opportunities
    • Rising demand for point of care (POC) coagulation testing
    • Technological advancements in coagulation & hemostasis testing
  • Market Challenges
    • Stringent and time-consuming regulatory processes

Porter's Five Forces: A Strategic Tool for Navigating the Coagulation & Hemostasis Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coagulation & Hemostasis Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coagulation & Hemostasis Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coagulation & Hemostasis Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coagulation & Hemostasis Testing Market

A detailed market share analysis in the Coagulation & Hemostasis Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coagulation & Hemostasis Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coagulation & Hemostasis Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coagulation & Hemostasis Testing Market

A strategic analysis of the Coagulation & Hemostasis Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coagulation & Hemostasis Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Danaher Corporation, Diagnostica Stago SAS, F. Hoffmann-La Roche Ltd., George King Bio-Medical, Inc., Grifols, S.A., Helena Laboratories Corporation, Medtronic PLC, Micropoint Biotechnologies Co., Ltd, Sekisui Chemical Co., Ltd., Siemens AG, Sysmex Corporation, Tcoag Ireland Limited, Thermo Fisher Scientific Inc., and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the Coagulation & Hemostasis Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing, and Platelet Function Tests.
  • Based on Technology, market is studied across Electrochemical Technology, Mechanical Technology, and Optical Technology.
  • Based on End-Use, market is studied across Diagnostic Centers, Hospitals, and Point-of-Care Testing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the Prevalence of cardiovascular diseases and blood disorders globally
      • 5.1.1.2. Increasing adoption of automated hemostasis equipment in diagnostic laboratories
      • 5.1.1.3. Availability of government initiatives focusing on awareness of hemophilia
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with fully automated coagulation systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for point of care (POC) coagulation testing
      • 5.1.3.2. Technological advancements in coagulation & hemostasis testing
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time-consuming regulatory processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Coagulation & Hemostasis Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Activated Partial Thromboplastin Time
  • 6.3. D-Dimer Testing
  • 6.4. Fibrinogen Testing
  • 6.5. Platelet Function Tests

7. Coagulation & Hemostasis Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Electrochemical Technology
  • 7.3. Mechanical Technology
  • 7.4. Optical Technology

8. Coagulation & Hemostasis Testing Market, by End-Use

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals
  • 8.4. Point-of-Care Testing

9. Americas Coagulation & Hemostasis Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Coagulation & Hemostasis Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Coagulation & Hemostasis Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Danaher Corporation
  • 3. Diagnostica Stago SAS
  • 4. F. Hoffmann-La Roche Ltd.
  • 5. George King Bio-Medical, Inc.
  • 6. Grifols, S.A.
  • 7. Helena Laboratories Corporation
  • 8. Medtronic PLC
  • 9. Micropoint Biotechnologies Co., Ltd
  • 10. Sekisui Chemical Co., Ltd.
  • 11. Siemens AG
  • 12. Sysmex Corporation
  • 13. Tcoag Ireland Limited
  • 14. Thermo Fisher Scientific Inc.
  • 15. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. COAGULATION & HEMOSTASIS TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COAGULATION & HEMOSTASIS TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COAGULATION & HEMOSTASIS TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COAGULATION & HEMOSTASIS TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COAGULATION & HEMOSTASIS TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY D-DIMER TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY FIBRINOGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PLATELET FUNCTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY MECHANICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY OPTICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. COAGULATION & HEMOSTASIS TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. COAGULATION & HEMOSTASIS TESTING MARKET, FPNV POSITIONING MATRIX, 2023